14th EORTC -- NCI -- AACR Symposium on 'molecular targets and cancer therapeutics'

To bring these new developments to patients as quickly and efficiently as possible requires international collaboration, early and optimal exchange of information, good quality translational research, efficient drug development and large prospective clinical trials.

Three of the world's leading cancer organisations -- the European Organisation for Research and Treatment of Cancer, the USA's National Cancer Institute and the American Association for Cancer Research are joining forces in Frankfurt from 19-22 November to provide a platform for presentation of the latest findings in drug research and development to around 2,000 international experts in the field.

All data at the four-day meeting are unpublished and being presented for the first time.

We welcome the media to the symposium. Every session is open to journalists and registration is free to bona fide media presenting official press credentials, or a letter from the editor of the journal they represent stating that they are being commissioned to write a report for publication.

A small media centre with computing, fax, photocopying and free international phone and internet connections will be available.

NB: the official language of the symposium is English and all press materials will be in English.

To register, contact:
Margaret Willson (media relations)
Fax: +44 (0) 1536 772191
Tel: +44 (0) 1536 772181
Email: [email protected]

More information on the programme is available on the EORTC website:
http://www.eortc.be/

Hotel accommodation can be booked through:
TOURISMUS + CONGRESS GMBH FRANKFURT AM MAIN
KAISERSTRASSE 56,
D-- 60329 FRANKFURT AM MAIN
Tel: +49 (0) 69 21 23 08 08
Fax: +49 (0) 69 21 24 05 12